Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
Post transplant cyclophosphamide, bortezomib and sitagliptin in 3+3 design to MTD
/
mega-study
Post transplant cyclophosphamide, bortezomib and sitagliptin in 3+3 design to MTD